To the full analysis
Apollo Hospitals Enterprise stock: growth
APOLLOHOSP.NSApollo Hospitals Enterprise reported $2.68B in revenue for fiscal 2026, up 15.8% on the prior year, up 19% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
18.8%
per year from 2007 to 2026, per share 16.7%
Earnings (Annual rate)
17.6%
per year from 2007 to 2026, per share 15.1%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 19.0% | 15.0% | 18.8% |
| Revenue per share | 18.4% | 14.7% | 16.7% |
| Earnings | 66.8% | 23.4% | 17.6% |
| Earnings per share | 65.9% | 23.0% | 15.1% |
| Free cash flow | −6.1% | no data | no data |
| Free cash flow per share | −6.6% | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $100.92M | $9.55M | −$11.71M |
| 2008 | $129.12M | $9.08M | −$18.81M |
| 2009 | $171.57M | $9.67M | −$29.89M |
| 2010 | $215.39M | $14.21M | −$20.86M |
| 2011 | $276.92M | $18.66M | −$7.94M |
| 2012 | $334.55M | $22.56M | −$791.53K |
| 2013 | $403.78M | $32.35M | −$23.11M |
| 2014 | $550.41M | $36.13M | −$25.35M |
| 2015 | $550.41M | $36.13M | −$42.32M |
| 2016 | $660.55M | $25.12M | −$43.36M |
| 2017 | $771.2M | $23.49M | −$17.09M |
| 2018 | $876.19M | $12.48M | −$8.97M |
| 2019 | $1.02B | $25.08M | $24.02M |
| 2020 | $1.2B | $48.35M | $82.88M |
| 2021 | $1.12B | $15.99M | $103.94M |
| 2022 | $1.56B | $112.2M | $103.18M |
| 2023 | $1.77B | $87.06M | $26.42M |
| 2024 | $2.03B | $95.51M | $83.27M |
| 2025 | $2.32B | $153.68M | $22.97M |
| 2026 | $2.68B | $206.38M | $75.7M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong since 7 Nov 2026, previously Neutral
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.